These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 31831431)

  • 21. Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine.
    Dalby T; Petersen JW; Harboe ZB; Krogfelt KA
    J Med Microbiol; 2010 Sep; 59(Pt 9):1029-1036. PubMed ID: 20508003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel multi-epitope peptide vaccine against cancer: an in silico approach.
    Nezafat N; Ghasemi Y; Javadi G; Khoshnoud MJ; Omidinia E
    J Theor Biol; 2014 May; 349():121-34. PubMed ID: 24512916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elucidation of linear epitopes of pertussis toxin using overlapping synthetic decapeptides: identification of a human B-cell determinant in the S1 subunit indicative of acute infections.
    Raupach B; Schmidt MA
    Microb Pathog; 1994 Oct; 17(4):213-26. PubMed ID: 7536288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epitope structure of the Bordetella pertussis protein P.69 pertactin, a major vaccine component and protective antigen.
    Hijnen M; Mooi FR; van Gageldonk PG; Hoogerhout P; King AJ; Berbers GA
    Infect Immun; 2004 Jul; 72(7):3716-23. PubMed ID: 15213111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical Trial.
    Blanchard Rohner G; Chatzis O; Chinwangso P; Rohr M; Grillet S; Salomon C; Lemaître B; Boonrak P; Lawpoolsri S; Clutterbuck E; Poredi IK; Wijagkanalan W; Spiegel J; Pham HT; Viviani S; Siegrist CA
    Clin Infect Dis; 2019 Mar; 68(7):1213-1222. PubMed ID: 30759183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploitation of reverse vaccinology and immunoinformatics as promising platform for genome-wide screening of new effective vaccine candidates against Plasmodium falciparum.
    Pritam M; Singh G; Swaroop S; Singh AK; Singh SP
    BMC Bioinformatics; 2019 Feb; 19(Suppl 13):468. PubMed ID: 30717656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of peptides that mimic the pertussis toxin binding site on bovine fetuin.
    Bogdan JA; Yuan W; Long-Rowe KO; Sarwar J; Brucker EA; Blake MS
    Appl Environ Microbiol; 2003 Oct; 69(10):6272-9. PubMed ID: 14532091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel configurations of high molecular weight species of the pertussis toxin vaccine component.
    Fowler S; Byron O; Jumel K; Xing D; Corbel MJ; Bolgiano B
    Vaccine; 2003 Jun; 21(19-20):2678-88. PubMed ID: 12744905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural vaccinology considerations for in silico designing of a multi-epitope vaccine.
    Negahdaripour M; Nezafat N; Eslami M; Ghoshoon MB; Shoolian E; Najafipour S; Morowvat MH; Dehshahri A; Erfani N; Ghasemi Y
    Infect Genet Evol; 2018 Mar; 58():96-109. PubMed ID: 29253673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computational analysis in designing T cell epitopes enriched peptides of Ebola glycoprotein exhibiting strong binding interaction with HLA molecules.
    Jain S; Baranwal M
    J Theor Biol; 2019 Mar; 465():34-44. PubMed ID: 30639295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conserved peptide vaccine candidates containing multiple Ebola nucleoprotein epitopes display interactions with diverse HLA molecules.
    Jain S; Baranwal M
    Med Microbiol Immunol; 2019 Apr; 208(2):227-238. PubMed ID: 30790057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of pertussis toxin encoded by ptx genes from Bordetella bronchiseptica to model the effects of antigenic drift of pertussis toxin on antibody neutralization.
    Hausman SZ; Burns DL
    Infect Immun; 2000 Jun; 68(6):3763-7. PubMed ID: 10816544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detoxification of pertussis toxin by site-directed mutagenesis: a review of connaught strategy to develop a recombinant pertussis vaccine.
    Loosmore S; Cockle S; Zealey G; Boux H; Phillips K; Fahim R; Klein M
    Mol Immunol; 1991 Mar; 28(3):235-8. PubMed ID: 1708104
    [No Abstract]   [Full Text] [Related]  

  • 34. Recombinant acellular pertussis vaccine--from the laboratory to the clinic: improving the quality of the immune response.
    Rappuoli R; Pizza M; Covacci A; Bartoloni A; Nencioni L; Podda A; De Magistris MT
    FEMS Microbiol Immunol; 1992 Oct; 5(4):161-70. PubMed ID: 1384602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines.
    Moise L; Gutierrez A; Kibria F; Martin R; Tassone R; Liu R; Terry F; Martin B; De Groot AS
    Hum Vaccin Immunother; 2015; 11(9):2312-21. PubMed ID: 26155959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neonatal immunization with a single dose of recombinant BCG expressing subunit S1 from pertussis toxin induces complete protection against Bordetella pertussis intracerebral challenge.
    Nascimento IP; Dias WO; Quintilio W; Christ AP; Moraes JF; Vancetto MD; Ribeiro-Dos-Santos G; Raw I; Leite LC
    Microbes Infect; 2008 Feb; 10(2):198-202. PubMed ID: 18248757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioinformatics analyses of immunogenic T-cell epitopes of LeIF and PpSP15 proteins from Leishmania major and sand fly saliva used as model antigens for the design of a multi-epitope vaccine to control leishmaniasis.
    Bordbar A; Bagheri KP; Ebrahimi S; Parvizi P
    Infect Genet Evol; 2020 Jun; 80():104189. PubMed ID: 31931259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergic effect of genotype changes in pertussis toxin and pertactin on adaptation to an acellular pertussis vaccine in the murine intranasal challenge model.
    Komatsu E; Yamaguchi F; Abe A; Weiss AA; Watanabe M
    Clin Vaccine Immunol; 2010 May; 17(5):807-12. PubMed ID: 20357056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epitope of the vaccine-type Bordetella pertussis strain 186 lipooligosaccharide and antiendotoxin activity of antibodies directed against the terminal pentasaccharide-tetanus toxoid conjugate.
    Niedziela T; Letowska I; Lukasiewicz J; Kaszowska M; Czarnecka A; Kenne L; Lugowski C
    Infect Immun; 2005 Nov; 73(11):7381-9. PubMed ID: 16239537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Modern strains of Bordetella pertussis: immunobiological properties and vaccine improvement].
    Shinkarev AS; Mertsalova NU; Mazurova IK; Borisova OIu; Zakharova NS; Ozeretskovskaia MN; Zaĭtsev EM; Poddubikov AV; Britsina MV; Bazhanova IG
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (4):20-5. PubMed ID: 17886371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.